Congenital afibrinogenemia is a bleeding disorder caused by impairment of the blood clotting process. Normally, blood clots protect the body after an injury by sealing off damaged blood vessels and preventing further blood loss. However, bleeding is uncontrolled in people with congenital afibrinogenemia. Newborns with this condition often experience prolonged bleeding from the umbilical cord stump after birth. Nosebleeds (epistaxis) and bleeding from the gums or tongue are common and can occur after minor trauma or in the absence of injury (spontaneous bleeding). Some affected individuals experience bleeding into the spaces between joints (hemarthrosis) or the muscles (hematoma). Rarely, bleeding in the brain or other internal organs occurs, which can be fatal. Women with congenital afibrinogenemia can have abnormally heavy menstrual bleeding (menorrhagia). Without proper treatment, women with this disorder may have difficulty carrying a pregnancy to term, resulting in repeated miscarriages.
[1]
S. Antonarakis,et al.
Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes
,
2001,
Human Genetics.
[2]
S. Antonarakis,et al.
Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia.
,
2000,
Blood.
[3]
P. Mannucci,et al.
Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia
,
1999,
British journal of haematology.
[4]
S. Antonarakis,et al.
Deletion of the fibrinogen [correction of fibrogen] alpha-chain gene (FGA) causes congenital afibrogenemia.
,
1999,
The Journal of clinical investigation.